Clinical performance evaluation of a novel rapid response chemiluminescent immunoassay for the detection of autoantibodies to extractable nuclear antigens
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
BACKGROUND: We analyzed the performance of a novel ENA screening chemiluminescent immunoassay (CIA) and the confirmation QUANTA Flash tests. METHODS: Sera (n=1079) from patients referred to a rheumatology clinic were screened by QUANTA Flash ENA7 (INOVA Diagnostics). All positive (n=89) and a matched control group (n=90) were reflexed for autoantibodies to the individual antigens. Moreover, sera from patients with systemic lupus erythematosus (SLE, n=252), systemic sclerosis (SSc, n=64), polymyositis/dermatomyositis (PM/DM, n=72), Sjögren's syndrome (SjS, n=39) as well as disease controls (n=605) were tested by ENA7 CIA and by Quanta Lite ENA6 ELISA (INOVA). RESULTS: 89/1079 (8.3%) samples were ENA7 CIA positive with the following reactivity profile: RNP (36.0%), Sm (13.5%), Scl-70 (9.0%), Jo-1 (0.0%), Ro60 (44.9%), Ro52 (39.3%) and SS-B (24.7%). In the negative group, the reactivity profile was: RNP (1.1%), Sm (1.1%), Scl-70 (2.2%) and 0.0% for Jo-1, Ro60, Ro52 and SS-B. The positive/negative/total agreements (ENA7 CIA vs. confirmation assays) were 95.3%/91.5%/93.3%. The sensitivity of the ENA7 CIA was 62.3% in SLE, 54.7% in SSc, 92.3% in SjS, 50.0% in PM/DM, and 61.8% in the total systemic autoimmune rheumatic disease (SARD) population (specificity 95.0%). CONCLUSION: The QUANTA Flash ENA7 CIA is a reliable screening test.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Advances and applications of multiplexed diagnostic technologies in autoimmune diseases
Fritzler, M. (2006) · Lupus · doi:10.1191/0961203306lu2327oa · Cited by 78 · cited 1×
“During the last 20 years several multiplex technologies have been developed and used in laboratory medicine [10,34].”
COPPLE, S. S., MARTINS, T. B., MASTERSON, C., JOLY, E., & HILL, H. R. (2007) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1398.052 · Cited by 42
Cited by
Chemiluminescent immunoassay technology: what does it change in autoantibody detection?
Cinquanta, L., Fontana, D. E., & Bizzaro, N. (2017) · Autoimmunity Highlights · doi:10.1007/s13317-017-0097-2 · Cited by 287
Detection of autoantibodies using chemiluminescence technologies
Mahler, M., Bentow, C., Serra, J., & Fritzler, M. J. (2016) · Immunopharmacology and Immunotoxicology · doi:10.3109/08923973.2015.1077461 · Cited by 47
Infantino, M., Meacci, F., Bentow, C., Martis, P., Benucci, M., Afeltra, A., Rigon, A., Atzeni, F., Sarzi-Puttini, P., Manfredi, M., et al. (2015) · Journal of Immunology Research · doi:10.1155/2015/902821 · Cited by 41
Self-citationBentow, C., Lakos, G., Martis, P., Wahl, E., Garcia, M., Viñas, O., Espinosa, G., Cervera, R., Sjöwall, C., Carmona-Fernandes, D., et al. (2016) · Lupus · doi:10.1177/0961203316640917 · Cited by 37
Self-citationZhao, J., Wang, K., Wang, X., Li, T., Guo, L., Gu, L., Chen, Z., Sun, F., Wang, H., Li, J., et al. (2018) · Clinical Rheumatology · doi:10.1007/s10067-017-3771-x · Cited by 22
Metadata
- Authors
- Bentow, C., Swart, A., Wu, J., Seaman, A., Manfredi, M., Infantino, M., Benucci, M., Lakos, G., & Mahler, M.
- Venue
- Clinica Chimica Acta
- Publisher
- Elsevier BV
- Published
- 2013-09
- Volume
- 424
- Pages
- 141-147
- ISSN
- 0009-8981 (ISSN-L)
- OpenAlex
- W1986968857
- Cited by
- 36
- References
- 2
- FWCI
- 4.36
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical performance evaluation of a novel rapid response chemiluminescent immunoassay for the detection of autoantibodies to extractable nuclear antigens. https://app.cochat.ai/papers/10.1016/j.cca.2013.05.011
- The paper
- Bentow, C., Swart, A., Wu, J., Seaman, A., Manfredi, M., Infantino, M., Benucci, M., Lakos, G., & Mahler, M. (2013). Clinical performance evaluation of a novel rapid response chemiluminescent immunoassay for the detection of autoantibodies to extractable nuclear antigens. Clinica Chimica Acta. https://doi.org/10.1016/j.cca.2013.05.011
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.